Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma
- 1Department of Thoracic Surgery, Daqing Longnan Hospital
Abstract
Background Although ion homeostasis in tumor development and treatment has drawn researchers’ attention, its prognostic role in lung adenocarcinoma (LUAD) remains unclear. Methods Differentially expressed genes (DEGs) between normal and LUAD samples (from The Cancer Genome Atlas cohort) were intersected with ion homeostasis-related genes (IHRGs) to yield differentially expressed IHRGs (DE-IHRGs). DE-IHRGs were screened by univariate, LASSO, and multivariate Cox regression to select signature genes and construct a predictive model. Two independent datasets (GSE72094 and GSE26939) were used for validation. Patients were dichotomized by the median ion homeostasis-related risk score (IHRS) into high- and low-IHRS groups, which were subjected to immune infiltration, tumor mutation, and drug sensitivity analyses. The expression of biomarker genes (SFXN1, GRIK2, C7, F2, RHCG) in LUAD cells was detected by qRT-PCR. In an SFXN1 knockdown cell model, the expression of the immune checkpoint protein PD-L1 was assessed by Western blot. In a co-culture system, the effects of SFXN1 on the cytotoxicity and proliferative capacity of CD8+ T cells were evaluated. Results A prognostic risk model was established using 15 ion homeostasis-related signature genes (SFXN1, RIC3, KCNK3, GRIK2, CFTR, F2RL1, ATP1A2, C7, F2, CPS1, EPB42, ATP6V0A4, CD52, SCN7A, and RHCG). Immune infiltration analysis revealed higher levels of immune cell infiltration, including B cells, mast cells, neutrophils, and macrophages, in the low-IHRS group. The high-IHRS group exhibited significantly higher tumor mutational burden and higher sensitivity to AZD6738, Docetaxel, and Savolitinib; the low-IHRS group showed greater sensitivity to Axitinib, BMS-754807, and MK-2206. In LUAD cells, SFXN1, GRIK2, F2, and RHCG were significantly upregulated, and C7 was downregulated. Functionally, SFXN1 knockdown suppressed PD-L1 expression and synergistically enhanced the cytotoxicity and proliferation of CD8+ T cells. Conclusion The established ion homeostasis-related prognostic model may assist in personalizing treatment strategies and predicting overall survival for LUAD.
Related
- Metabolic signature of phosphoethanolamine and arginine pathways predicts prognosis and immunotherapy resistance in lung adenocarcinoma
- Construction of a prognostic model and immune landscape analysis for lung adenocarcinoma utilizing a bioinformatics signature derived from acrolein-related genes, and identification of associated subtypes.
- ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma
- A tumor purity-based gene signature predicts prognosis and shapes the immune microenvironment in PAAD
- A T-cell exhaustion-related signature for predicting response to immunotherapy among patients with lung adenocarcinoma
BibTeX
@article{zhang2026homeostasis,
title = {{Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma}},
author = {Ming Zhang and Tao Liu},
journal = {Discover Oncology},
year = {2026},
month = jul,
doi = {10.1007/s12672-026-05490-3},
url = {https://doi.org/10.1007/s12672-026-05490-3},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma
AU - Ming Zhang
AU - Tao Liu
PY - 2026
DA - 2026/07/01
JO - Discover Oncology
DO - 10.1007/s12672-026-05490-3
UR - https://doi.org/10.1007/s12672-026-05490-3
AB - Background Although ion homeostasis in tumor development and treatment has drawn researchers’ attention, its prognostic role in lung adenocarcinoma (LUAD) remains unclear. Methods Differentially expressed genes (DEGs) between normal and LUAD samples (from The Cancer Genome Atlas cohort) were intersected with ion homeostasis-related genes (IHRGs) to yield differentially expressed IHRGs (DE-IHRGs). DE-IHRGs were screened by univariate, LASSO, and multivariate Cox regression to select signature genes and construct a predictive model. Two independent datasets (GSE72094 and GSE26939) were used for validation. Patients were dichotomized by the median ion homeostasis-related risk score (IHRS) into high- and low-IHRS groups, which were subjected to immune infiltration, tumor mutation, and drug sensitivity analyses. The expression of biomarker genes (SFXN1, GRIK2, C7, F2, RHCG) in LUAD cells was detected by qRT-PCR. In an SFXN1 knockdown cell model, the expression of the immune checkpoint protein PD-L1 was assessed by Western blot. In a co-culture system, the effects of SFXN1 on the cytotoxicity and proliferative capacity of CD8+ T cells were evaluated. Results A prognostic risk model was established using 15 ion homeostasis-related signature genes (SFXN1, RIC3, KCNK3, GRIK2, CFTR, F2RL1, ATP1A2, C7, F2, CPS1, EPB42, ATP6V0A4, CD52, SCN7A, and RHCG). Immune infiltration analysis revealed higher levels of immune cell infiltration, including B cells, mast cells, neutrophils, and macrophages, in the low-IHRS group. The high-IHRS group exhibited significantly higher tumor mutational burden and higher sensitivity to AZD6738, Docetaxel, and Savolitinib; the low-IHRS group showed greater sensitivity to Axitinib, BMS-754807, and MK-2206. In LUAD cells, SFXN1, GRIK2, F2, and RHCG were significantly upregulated, and C7 was downregulated. Functionally, SFXN1 knockdown suppressed PD-L1 expression and synergistically enhanced the cytotoxicity and proliferation of CD8+ T cells. Conclusion The established ion homeostasis-related prognostic model may assist in personalizing treatment strategies and predicting overall survival for LUAD.
SN - 2730-6011
ER -